These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21987544)

  • 1. Continuous epileptiform discharges in patients treated with cefepime or meropenem.
    Naeije G; Lorent S; Vincent JL; Legros B
    Arch Neurol; 2011 Oct; 68(10):1303-7. PubMed ID: 21987544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital.
    Angkasekwinai N; Werarak P; Chaiyasoot K; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S217-24. PubMed ID: 21721450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
    Sonck J; Laureys G; Verbeelen D
    Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem.
    Tanaka A; Takechi K; Watanabe S; Tanaka M; Suemaru K; Araki H
    Int J Clin Pharm; 2013 Oct; 35(5):683-7. PubMed ID: 23733559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal failure is a risk factor for cefepime-induced encephalopathy.
    Garces EO; Andrade de Anzambuja MF; da Silva D; Bragatti JA; Jacoby T; Saldanha Thomé F
    J Nephrol; 2008; 21(4):526-34. PubMed ID: 18651542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
    Peyko V; Smalley S; Cohen H
    J Pharm Pract; 2017 Apr; 30(2):209-213. PubMed ID: 26912532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convulsive liability of cefepime and meropenem in normal and corneal kindled mice.
    Tanaka A; Takechi K; Watanabe S; Tanaka M; Suemaru K; Araki H
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4380-3. PubMed ID: 24841261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug utilization evaluation of meropenem and correlation of side effects with renal status of patients in a teaching based hospital.
    Khan MU; Yousuf RI; Shoaib MH
    Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1503-8. PubMed ID: 25176244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of generic formulation of meropenem (Penem) for treatment of infections at Siriraj Hospital.
    Angkasekwinai N; Werarak P; Tongsai S; Thamlikitkul V
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S34-41. PubMed ID: 22574527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
    Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
    Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug utilization study of two generic antibiotics in a tertiary hospital in Bogotá.
    López JJ; Cortázar Y; Acosta Á; Vargas-Peláez CM; Rossi F
    Biomedica; 2018 Sep; 38(3):398-406. PubMed ID: 30335245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
    Patel GW; Duquaine SM; McKinnon PS
    Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroencephalographic findings in acute subdural hematoma.
    Rudzinski LA; Rabinstein AA; Chung SY; Wong-Kisiel LC; Burrus TM; Lanzino G; Westmoreland BF
    J Clin Neurophysiol; 2011 Dec; 28(6):633-41. PubMed ID: 22146350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
    Goethaert K; Van Looveren M; Lammens C; Jansens H; Baraniak A; Gniadkowski M; Van Herck K; Jorens PG; Demey HE; Ieven M; Bossaert L; Goossens H
    Clin Microbiol Infect; 2006 Jan; 12(1):56-62. PubMed ID: 16460547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cognitive impact of epileptiform EEG-discharges; relationship with type of cognitive task.
    Aldenkamp AP; Arends J; Verspeek S; Berting M
    Child Neuropsychol; 2004 Dec; 10(4):297-305. PubMed ID: 15621851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
    Kim A; Kuti JL; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.